Neuromuscular electrical stimulation can preserve and rebuild muscle when ordinary training is impossible — in ICU beds, after surgery, in older adults who cannot lift — but its effects run smaller than voluntary exercise, and the six-pack marketing claims have drawn regulatory warnings.

Here is what a course of neuromuscular electrical stimulation actually consists of, itemized. Two or more adhesive electrodes, placed on the skin over a target muscle. A device that delivers timed electrical impulses through those electrodes. Involuntary contractions — the muscle firing without the brain's permission — that reproduce aspects of resistance exercise. A preferential recruitment of fast-twitch, type II fibers, the ones aging loses first. In the whole-body variant, a wired suit stimulating several large muscle groups at once while the wearer performs light movement. And a list of places the current must never go: over a pacemaker or implanted defibrillator, over the anterior neck, over a pregnant abdomen, over broken skin.
That odd inventory — part rehabilitation clinic, part warning label — frames the question this article answers: for whom does electrical muscle stimulation demonstrably work, and for whom is it an expensive tingling? The most defensible answer the trials permit is that EMS is a genuine tool for people who cannot exercise normally, and a much weaker proposition for everyone else.
The most compelling use case is the one where voluntary exercise is impossible. In a randomized controlled trial published in Nursing in Critical Care in 2023, neuromuscular electrical stimulation was tested against ICU-acquired weakness in mechanically ventilated patients — people whose muscles waste while machines breathe for them. In 2022, a trial in the Annals of Physical and Rehabilitation Medicine found that NMES after cardiovascular surgery mitigated muscle weakness in older patients with diabetes. Controlled trials of leg immobilization and post-knee-surgery recovery point the same direction: stimulation attenuates the loss of muscle mass and strength during disuse, and cellular studies show preserved muscle-fiber size and contractility — the machine keeping the tissue's architecture intact when the person cannot. Quadriceps strength, specifically, rises across the controlled literature.
Sarcopenia — the age-related slide in muscle mass and function — is where EMS marketing meets a real problem. Whole-body EMS trials and meta-analyses in older adults report gains in muscle mass, strength, and sarcopenia scores, and a 2025 systematic review and meta-analysis in Nutrients examined exercise, nutrition, and NMES together for sarcopenic obesity in middle-aged and older adults. A 2021 scoping review in Physical Therapy mapped the evidence on quadriceps strength and mass in healthy young and older adults and found the signal real but the literature thin — evidence in healthy older adults remains limited. The positioning that survives scrutiny: a joint-sparing option for people unable or unwilling to perform conventional resistance training.
Three honest limits belong at the center of this story, not the footnotes. First, across comparisons, the effects of electrical stimulation are generally smaller than those of voluntary exercise — current can make a muscle contract, but it does not replicate the full systemic stimulus of training. Second, the effects on fat loss and pain are minor or absent. Third, regulators have warned that the effortless ab-stimulator marketing — watch television, acquire definition — is unsupported. The device that preserves a ventilated patient's quadriceps and the belt promising a six-pack share a technology and almost nothing else. A 2018 paper in Artificial Organs documents the underlying muscle-contraction mechanism, which is real physiology; the leap from physiology to couch-based transformation is the part with no evidence behind it.
If you or someone you love faces immobilization, surgery recovery, or an inability to perform resistance exercise, NMES is worth discussing with a rehabilitation professional — that is precisely the population the trials support. If you are healthy and able-bodied, the honest reading is that electricity complements training rather than replacing it, at smaller effect size. Respect the contraindication list without exception: implanted cardiac devices, the anterior neck, pregnancy, broken skin.
Read the inventory once more — electrodes, impulses, fast-twitch fibers, forbidden zones — and a coherent device emerges: a clinical tool that wandered into the fitness aisle. The current does what the trials say it does. It was never going to do the rest. Educational, not medical advice.
EMS has legitimate, trial-backed value for preventing muscle loss during immobilization and illness and for building strength in people unable to do conventional resistance training — but it is a rehabilitation modality, not a shortcut past exercise, and it is contraindicated with pacemakers and over the neck, pregnant abdomen, or broken skin.
5 peer-reviewed sources, published 2018–2025, across 5 journals. 3 of them have a full Magellan study write-up linked below.
Each links to its Magellan monograph — what it is, what it does, and the studies behind it.
Evidence suggests blood flow restriction training effectively increases muscle strength and mass in older…
Percussive massage guns reliably loosen joints and blunt next-day soreness in controlled trials — and just…
A look at the evidence for sauna, cold plunge, and red-light therapy in promoting longevity and healthspan.
All Magellan articles → · More on Recovery, Sauna & Light Therapy →
Prefer the interactive version? Open this article inside the Magellan app →